Chu‐Xia Deng
0000-0001-8033-3902
Publication & Citation Trends
Publications
597 total
The heterogeneity of signaling pathways and drug responses in intrahepatic cholangiocarcinoma with distinct genetic mutations OA
Cited by 10
Semantic Scholar
Revealing the secret behind Epstein‐Barr virus‐specific tumor immune contexture OA
Cited by 1
Semantic Scholar
Sirt6 ablation in the liver causes fatty liver that increases cancer risk by upregulating Serpina12 OA
Cited by 2
Semantic Scholar
Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple‐Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy OA
Cited by 0
Semantic Scholar
Fueling sentinel node via reshaping cytotoxic T lymphocytes with a flex-patch for post-operative immuno-adjuvant therapy OA
Cited by 33
Semantic Scholar
Cutoff value of IC50 for drug sensitivity in patient-derived tumor organoids in colorectal cancer OA
Cited by 19
Semantic Scholar
Visible-light-induced strong oxidation capacity of metal-free carbon nanodots through photo-induced surface reduction for photocatalytic antibacterial and tumor therapy.
Cited by 21
Semantic Scholar
BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance OA
Cited by 15
Semantic Scholar
Research Topics
Extracellular vesicles in disease
(110)
MicroRNA in disease regulation
(79)
Cancer-related molecular mechanisms research
(58)
Sarcoma Diagnosis and Treatment
(57)
Cancer Research and Treatments
(54)
Affiliations
Tongji University
University of Iowa
University of Maryland, Baltimore
National Institutes of Health
Howard Hughes Medical Institute